Table 3.
Outcomes | Subgroups | Effect estimate | ||||
---|---|---|---|---|---|---|
Studies | χ2 | MD and 95% CI | I 2 (%) | P | ||
VAS at POD0 | CFNB | 2 | 0.07 | 0.42(−0.02,0.86) | 0 | 0.8 |
SFNB | 4 | 35.91 | 0.03(−0.73,0.78) | 92 | <0.00001 | |
VAS at POD1 | CFNB | 2 | 0.17 | 0.49(0.09,0.9) | 0 | 0.68 |
SFNB | 3 | 23.53 | '‐0.48(−1.54,0.59) | 91 | <0.00001 | |
Total morphine | CFNB | 2 | 0.01 | −70.97(−104.11, −37.83) | 0 | 0.93 |
SFNB | 4 | 535.92 | −36.51(−82.86,9.83) | 99 | <0.00001 | |
LOS | CFNB | 4 | 1.85 | −0.36(−0.53,−0.19) | 0 | 0.6 |
SFNB | 5 | 11.82 | −0.22(−0.41,−0.03) | 66 | 0.02 |